期刊文献+

胃癌组织中VEGF-D及MLVD表达及其与预后的关系 被引量:5

Relationship between Expression of VEGF-D and MLVD in Gastric Cancer Tissues and Prognosis
下载PDF
导出
摘要 目的探讨胃癌患者肿瘤组织中血管内皮生长因子-D(vascular endothelial growth factor-D,VEGF-D)及微淋巴管密度(micro-lymphatic vessel density,MLVD)与其生存期的关系。方法收集52例胃癌术后患者标本,采用免疫组化方法检测胃癌组织中VEGF-D、MLVD及胃癌癌旁MLVD。结合临床病理资料,分析VEGF-D、MLVD与其生存期的关系。结果胃癌组织VEGF-D阳性组生存期较阴性组短(P=0.048),两者间差异有统计学意义;癌旁组织MLVD高组(≥10)较低组(<10)生存期短(P=0.001),两者间差异有统计学意义;胃癌组织MLVD高组(≥10)较低组(<10)生存期短(P=0.067),但差异无明显统计学意义。结论胃癌组织中VEGF-D及胃癌癌旁MLVD可作为判断胃癌预后的指标。 Objective To study the relationships between expression of vascular endothelial growth factor-D( VEGF-D)and micro-lymphatic vessel density( MLVD) of gastric cancer tissues and overall survival. Methods 52 samples of resected gastric cancer were gathered. The expression of VEGF-D in gastric cancer,intratumoral MLVD and peritumoral MLVD were stained immunohistochemically. Clinical data and stastistical analysis were combined to find the relationship in VEGF-D,MLVD and overall survival. Results The overall survival of VEGF-D positive group was significantly shorter than that of negative group( P =0. 048). There was statistical difference between the 2 groups. The overall survival of peritumoral high MLVD group( ≥10) was significantly shorter than that of low MLVD group( 〈10)( P = 0. 001). There was statistically difference between the 2 groups.But the overall survival of intratumoral high MLVD group( ≥10) was not statistically shorter than low MLVD group( 〈10)( P =0. 067). Conclusion The detection of VEGF-D and peritumoral MLVD in the tissue of gastric cancer can be regarded as unfavorable prognostic indicator for patients with gastric cancer.
出处 《实用癌症杂志》 2016年第1期39-42,58,共5页 The Practical Journal of Cancer
关键词 胃肿瘤 血管内皮生长因-D 微淋巴管密度 免疫组织化学 预后 生存期 Stomach neoplasms Vascular endothelial growth factor-D(VEGF-D) Micro-lymphatic vessel density(MLVD) Immunohistochemistry Prognosis Survival time
  • 相关文献

参考文献19

  • 1陈灏珠,林果为.实用内科学[M].第13版.北京:人民卫生出版社,2009:2005-2011.
  • 2周际昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2005.386-388.
  • 3Cao R, Bj~rndahl MA, Reliqa P, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis[J~. Cancer Ce11,2004,6(4) :333-345.
  • 4Achen MG, Jehsch M, Kukk E, et al. Vascular endothelial growth factor D(VEGF-D) is a ligand for the tyrosine di- nases VEGF receptor 2 ( Flkl ) and VEGF receptor 3 (Fh4) [ J ~. Proc Natl Acad Sci USA, 1998,95 (2) :548-553.
  • 5Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor-C exptression predicts lymph node metastasis of human gastric carcinomas invading the submucosa [ J~. Eur J Cancer,2002,38 (10) : 1413-1419.
  • 6邢传平,刘斌,董亮.免疫组织化学标记结果的判断方法[J].中华病理学杂志,2001,30(4):318-318. 被引量:206
  • 7Ohno M, Nakamura T, Kunimoto Y, et al. Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer [ J ~. Oncol Rep, 2003, 10 (4) :939-943.
  • 8Wang XL, Fang JP, Tang RY, et al. Different significance between intratuomoral and peritumoral iymphatic vessel density in gastric caneer:a retrospective study of 123 cans- es ~ J 3. BMC cancer,2010,10:299.
  • 9Rudno-Rudzinska J, Kielan W, Grzebieniak Z, et al. High density of peritumoral lymphatic vessels measured by D2- 40/podoplanin and LYVE-1 expression in gastric cancer patients:an excellent prognostic indicator or a false friend f .1]. Gastric Cancer,2013,16(4) :513-520.
  • 10Deng J, Liang H, Sun D, et al. Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy [ J 1- Surgery, 2009, 146 (5) : 896-905.

二级参考文献26

  • 1Karpanen T,Egeblad M,Karkkainen MJ. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth[J].CANCER RESEARCH,2001.1786-1790.
  • 2Shimizu K,Kubo H,Yamaguchi K. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer[J].Cancer Science,2004.328-333.
  • 3Strippoli GF,Bonifati C,Craig M. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease[J].Cochrane Database of Systematic Reviews,2006.CD006257.
  • 4Lever AF,Hole DJ,Gillis CR. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer[J].The Lancet,1998.179-184.
  • 5Chen L,Re RN,Prakash 0. Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate[J].Proceedings of the Society for Experimental Biology and Medicine,1991.280-283.
  • 6Uemura H,Ishiguro H,Nakaigawa N. Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells:a possibility of tyrosine kinase inhibitor of growth factor[J].Molecular Cancer Therapeutics,2003.1139-1147.
  • 7Egami K,Murohara T,Shimada T. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth[J].Journal of Clinical Investigation,2003.67-75.
  • 8Miyajima A,Kosaka T,Asano T. Angiotensin Ⅱ typeI antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis[J].Cancer Research,2002.4176-4179.
  • 9Fernando NH,Hurwitz HI. Targeted therapy of colorectal cancer:clinical experience with bevacizumab[J].Oncologist(The),2004,(z 1):11-18.doi:10.1634/theoncologist.9-suppl_1-11.
  • 10Nouet S,Nahmias C. Signal transduction from the angiotensin Ⅱ AT2 receptor[J].Trends in Endocrinology and Metabolism,2000.1-6.

共引文献727

同被引文献57

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部